MedTrace Logo

Lupus Landmark Study: A Prospective Registry and Biorepository

NCT05934149 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3500

Last updated 2026-04-15

No results posted yet for this study

Summary

The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).

Conditions

  • Systemic Lupus Erythematosus (SLE)
  • Lupus Nephritis
  • Neuropsychiatric Systemic Lupus Erythematosus

Sponsors & Collaborators

  • Lupus Research Alliance

    lead OTHER

Principal Investigators

  • Sam Lim, MD, MPH · Emory University

  • Arezou Khosroshahi, MD · Emory University

  • Alfred Kim, MD, PhD · Washington University School of Medicine

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-28
Primary Completion
2035-12-31
Completion
2035-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05934149 on ClinicalTrials.gov